EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic profiling identifies candidate biomarkers for small intestinal neuroendocrine tumours G1 and G2

Malin Grönberg iD, Dimitrios Papantoniou iD, Eva Tiensuu Janson iD

Journal of Neuroendocrinology · 2026-10 · 38 (10)

DOI: 10.1111/jne.70289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 09.10.2026. Verfasst von Malin Grönberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Endocrine Oncology, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Biomarkers, Tumor, Intestinal Neoplasms, Intestine, Small. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Swedish Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although small intestinal neuroendocrine tumours (SI‐NET) Grade 1 (G1) and 2 (G2) are often studied together, clinical course and response to treatment may differ. We hypothesized that these tumour groups express different markers in blood that may inform future treatment strategies. Blood from 107 SI‐NET patients (G1 n = 64, G2 n = 43) and 50 healthy controls was analysed with proximity extension assay (Olink, Uppsala, Sweden). Two oncology protein panels were used. Outcomes were analysed with regression analysis and machine learning algorithms (Random Forest, Boruta). In age‐adjusted analyses, 188 proteins differed between patients and healthy controls, with most being elevated in patients. Six proteins were elevated in G2 vs. G1 patients. After adjusting for age, Retbindin (RTBDN), Cryptic family protein 1 (CFC1), and Calbindin 1 (CALB1) remained significant, while adjusting for age and stage left only RTBDN significant. In a stage IV‐restricted analysis, RTBDN was higher in G2 than in G1 (estimate 1.688; 95% CI 0.796–2.580; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsBiomarkers, TumorIntestinal NeoplasmsIntestine, SmallHumansFemaleMaleProteomicsMiddle AgedAgedAdult

Stichwörter der Autor:innen

neuroendocrine neoplasiaolinksmall intestinal neuroendocrine tumourstumour biomarkers

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Sciences, Endocrine Oncology, Uppsala University, Uppsala, Sweden.
  • Department of Oncology, Ryhov County Hospital, Jönköping, Sweden.
  • Department of Medical Sciences, Endocrine Oncology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

ORCID-Profile: Malin Grönberg, Dimitrios Papantoniou, Eva Tiensuu Janson

Förderung

  • Swedish Cancer Society
  • Swedish Cancer Foundation

Zitieren

APA

Grönberg, M., Papantoniou, D., & Janson, E. T. (2026). Proteomic profiling identifies candidate biomarkers for small intestinal neuroendocrine tumours G1 and G2. Journal of Neuroendocrinology, 38(10). https://doi.org/10.1111/jne.70289

Vancouver

Grönberg M, Papantoniou D, Janson ET. Proteomic profiling identifies candidate biomarkers for small intestinal neuroendocrine tumours G1 and G2. Journal of Neuroendocrinology. 2026;38(10). doi:10.1111/jne.70289

BibTeX
@article{Grnberg2026,
  author = {Grönberg, Malin and Papantoniou, Dimitrios and Janson, Eva Tiensuu},
  title = {Proteomic profiling identifies candidate biomarkers for small intestinal neuroendocrine tumours G1 and G2},
  journal = {Journal of Neuroendocrinology},
  year = {2026},
  volume = {38},
  number = {10},
  doi = {10.1111/jne.70289}
}
Kostenlos starten →